Skip to main content
. Author manuscript; available in PMC: 2010 Aug 3.
Published in final edited form as: J Infect Dis. 2009 May 1;199(9):1360–1368. doi: 10.1086/597806

Figure 5.

Figure 5

Serum bactericidal titers against epidemic group A, W-135 and X strains. Eight strains were from Africa and 2 (LNP17592 and LNP19995) were Hajj-related sequence type (ST)–11, W-135 case isolates from France. All of the strains had heterologous PorA from the vaccine strains. The multilocus STs are shown in parentheses. The vaccine groups were as follows: Native outer membrane vesicle (OMV), Mutant (with “Mutant” denoting LpxL1 knockout strains of H44/76 and NZ98/254 expressing fHbp variant 1 and variant 2); Detergent OMV, WT (detergent-treated OMV from respective wild-type strain); and Al(OH)3 (aluminum hydroxide only).

HHS Vulnerability Disclosure